4//SEC Filing
MPM BIOVENTURES III QP LP 4
Accession 0001209191-09-004718
CIK 0001408808other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 6:18 PM ET
Size
28.7 KB
Accession
0001209191-09-004718
Insider Transaction Report
Form 4
PEPLIN INCPLIN
MPM BioVentures IV LLC
10% Owner
Transactions
- Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote)
MPM BIOVENTURES III LLC
10% Owner
Transactions
- Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote)
MPM BIOVENTURES III LP
10% Owner
Transactions
- Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote)
MPM BIOVENTURES III QP LP
10% Owner
Transactions
- Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote)
MPM BioVentures IV QP LP
10% Owner
Transactions
- Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote)
MPM BioVentures IV GP LLC
10% Owner
Transactions
- Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote)
Transactions
- Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote)
MPM BIOVENTURES III GP LP
10% Owner
Transactions
- Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote)
Transactions
- Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote)
Transactions
- Purchase
Common Stock
2009-01-21$8.00/sh+932$7,456→ 3,402,871 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.20/sh+1,249$10,242→ 3,404,120 total(indirect: See Footnote) - Purchase
Common Stock
2009-01-22$8.00/sh+1,334$10,672→ 3,405,454 total(indirect: See Footnote)
Footnotes (7)
- [F1]Represents shares of Common Stock underlingy CHESS Depository Interests ("CDIs") acquired by the reporting persons. CDIs are units of beneficial ownership in shares of Common Stock held by CHESS Depositary Nominees Pty Limited, a wholly-owned subsidiary of the Australian Stock Exchange. The CDIs are economically equivalent to shares of Common Stock of the Issuer on a 1-for-20 basis.
- [F2]The Common Stock equivalent of CDIs were purchased as follows: 875 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 33 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 24 by MPM Asset Management Investors BV4 LLC ("AM BV4"). Excludes fractional shares that result from the conversion of CDIs. MPM BioVentures IV GP LLC and MPM BioVentures IV LLC are the direct and indirect general partners of BV IV QP, BV IV KG and AM BV4. Vaughn M. Kailian, Ansbert Gadicke, Luke Evnin, Steven St. Peter, William Greene, James Paul Scopa, Ashley Dombkowski and John Vander Vort are the members of the general partner of BV IV QP, BV IV KG and members of AM BV4. MPM BioVentures III GP, L.P. ("BV III GP") and MPM BioVentures III LLC ("BV III LLC") are the direct and indirect general partners of MPM BioVentures III, LP. ("BV III"), MPM BioVentures III-QP, LP ("BV III QP"), MPM BioVentures III Parallel Fund, LP ("BV III PF"), MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV III KG") and MPM BioVentures Strategic Fund, LP ("BV SF"). Luke Evnin and Ansbert Gadicke are Series A members of BV III LLC and managers of AM BV III. Each member of the group disclaims beneficial ownership of the securities except to the extent of his, her or its respective pecuniary interest therein.
- [F3]Shares of Common Stock, which include shares underlying CDIs are held as follows: 2,702,139 by BV IV QP, 104,098 by BV IV KG, 76,834 by AM BV4, 25,510 by BV III, 379,381 by BV III QP, 32,061 by BV III KG, 11,456 by BV III PF, 9,017 by AM BV III and 62,375 by BV SF. Each member of the group disclaims beneficial ownership of the securities except to the extent of his, her or its respective pecuniary interest therein.
- [F4]The Common Stock equivalent of CDIs were purchased as follows: 1,171 by BV IV QP, 45 by BV IV KG and 33 by AM BV4. Excludes fractional shares that result from the conversion of CDIs. Each member of the group disclaims beneficial ownership of the securities except to the extent of his, her or its respective pecuniary interest therein.
- [F5]Shares of Common Stock, which include shares underlying CDIs are held as follows: 2,703,310 by BV IV QP, 104,143 by BV IV KG, 76,867 by AM BV4, 25,510 by BV III, 379,381 by BV III QP, 32,061 by BV III KG, 11,456 by BV III PF, 9,017 by AM BV III and 62,375 by BV SF. Each member of the group disclaims beneficial ownership of the securities except to the extent of his, her or its respective pecuniary interest therein.
- [F6]The Common Stock equivalent of CDIs were purchased as follows: 1,251 by BV IV QP, 48 by BV IV KG and 35 by AM BV4. Excludes fractional shares that result from the conversion of CDIs. Each member of the group disclaims beneficial ownership of the securities except to the extent of his, her or its respective pecuniary interest therein.
- [F7]Shares of Common Stock, which include shares underlying CDIs are held as follows: 2,704,561 by BV IV QP, 104,191 by BV IV KG, 76,902 by AM BV4, 25,510 by BV III, 379,381 by BV III QP, 32,061 by BV III KG, 11,456 by BV III PF, 9,017 by AM BV III and 62,375 by BV SF. Each member of the group disclaims beneficial ownership of the securities except to the extent of his, her or its respective pecuniary interest therein.
Documents
Issuer
PEPLIN INC
CIK 0001408808
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001173409
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 6:18 PM ET
- Size
- 28.7 KB